These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

580 related articles for article (PubMed ID: 27145899)

  • 1. Pharmaceutical liposomal drug delivery: a review of new delivery systems and a look at the regulatory landscape.
    Zylberberg C; Matosevic S
    Drug Deliv; 2016 Nov; 23(9):3319-3329. PubMed ID: 27145899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liposomal drug delivery systems: from concept to clinical applications.
    Allen TM; Cullis PR
    Adv Drug Deliv Rev; 2013 Jan; 65(1):36-48. PubMed ID: 23036225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elastic liposomes as novel carriers: recent advances in drug delivery.
    Hussain A; Singh S; Sharma D; Webster TJ; Shafaat K; Faruk A
    Int J Nanomedicine; 2017; 12():5087-5108. PubMed ID: 28761343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent Progress in Bioconjugation Strategies for Liposome-Mediated Drug Delivery.
    Almeida B; Nag OK; Rogers KE; Delehanty JB
    Molecules; 2020 Dec; 25(23):. PubMed ID: 33271886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lyophilized liposome-based parenteral drug development: Reviewing complex product design strategies and current regulatory environments.
    Wang Y; Grainger DW
    Adv Drug Deliv Rev; 2019; 151-152():56-71. PubMed ID: 30898571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ligation strategies for targeting liposomal nanocarriers.
    Marqués-Gallego P; de Kroon AI
    Biomed Res Int; 2014; 2014():129458. PubMed ID: 25126543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug-in-cyclodextrin-in-liposomes: a promising delivery system for hydrophobic drugs.
    Chen J; Lu WL; Gu W; Lu SS; Chen ZP; Cai BC; Yang XX
    Expert Opin Drug Deliv; 2014 Apr; 11(4):565-77. PubMed ID: 24490763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The potential of liposomes as dental drug delivery systems.
    Nguyen S; Hiorth M; Rykke M; Smistad G
    Eur J Pharm Biopharm; 2011 Jan; 77(1):75-83. PubMed ID: 20875853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liposomal drug delivery systems: an update review.
    Samad A; Sultana Y; Aqil M
    Curr Drug Deliv; 2007 Oct; 4(4):297-305. PubMed ID: 17979650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A review on novel vesicular drug delivery: proniosomes.
    Yasam VR; Jakki SL; Natarajan J; Kuppusamy G
    Drug Deliv; 2014 Jun; 21(4):243-9. PubMed ID: 24128089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Innovations in Liposomal DDS Technology and Its Application for the Treatment of Various Diseases.
    Oku N
    Biol Pharm Bull; 2017; 40(2):119-127. PubMed ID: 28154249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Challenges in development of targeted liposomal therapeutics.
    Sawant RR; Torchilin VP
    AAPS J; 2012 Jun; 14(2):303-15. PubMed ID: 22415612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular Design of Layer-by-Layer Functionalized Liposomes for Oral Drug Delivery.
    Lai WF; Wong WT; Rogach AL
    ACS Appl Mater Interfaces; 2020 Sep; 12(39):43341-43351. PubMed ID: 32877163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enzymatic action of phospholipase A₂ on liposomal drug delivery systems.
    Hansen AH; Mouritsen OG; Arouri A
    Int J Pharm; 2015 Aug; 491(1-2):49-57. PubMed ID: 26056930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A tumor vasculature targeted liposome delivery system for combretastatin A4: design, characterization, and in vitro evaluation.
    Nallamothu R; Wood GC; Pattillo CB; Scott RC; Kiani MF; Moore BM; Thoma LA
    AAPS PharmSciTech; 2006 Apr; 7(2):E32. PubMed ID: 16796350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential.
    Immordino ML; Dosio F; Cattel L
    Int J Nanomedicine; 2006; 1(3):297-315. PubMed ID: 17717971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The liposomal formulation of doxorubicin.
    Abraham SA; Waterhouse DN; Mayer LD; Cullis PR; Madden TD; Bally MB
    Methods Enzymol; 2005; 391():71-97. PubMed ID: 15721375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Nanostructured liposomal systems as transport agents for anticancer drugs].
    Baryshnikov AIu
    Vestn Ross Akad Med Nauk; 2012; (3):23-31. PubMed ID: 22712271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intradermal and follicular delivery of adapalene liposomes.
    Kumar V; Banga AK
    Drug Dev Ind Pharm; 2016; 42(6):871-9. PubMed ID: 27031916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stimuli-responsive Smart Liposomes in Cancer Targeting.
    Jain A; Jain SK
    Curr Drug Targets; 2018 Feb; 19(3):259-270. PubMed ID: 26853324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.